Jim Simons acquired 832 Thousand Veracyte shares worth $22 Million. That's 0.03% of their equity portfolio (607th largest holding). The investor owns 1.06% of the outstanding Veracyte stock. The first Veracyte trade was made in Q4 2015. Since then Jim Simons bought shares sixteen more times and sold shares on eleven occasions. The investor's estimated purchase price is $23.6 Million, resulting in a loss of 7.1%.